Siemens Atellica IM Folate 140 test kit recalled for measurement bias
Siemens is recalling the Atellica IM Folate 140 test kit due to negative bias that occurs when whole blood calibration is mistakenly used to test serum samples, potentially producing falsely low folate measurements.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II medical device with risk of harm from inaccurate diagnostic results (negative bias producing false-low folate measurements). No illnesses or injuries have been reported, placing it in the High severity category per the rubric for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling the Atellica IM Folate 140 test kit, an in vitro diagnostic device used to measure folate levels in human serum and red blood cells. The recall affects approximately 13,843 kits distributed nationwide and internationally, including lot numbers 15308337, 27949339, 41143343, 41144343, 62969345, and higher.
The device was recalled due to negative bias that occurs when whole blood calibration (from Atellica IM Folate or ADVIA Centaur FolateBA/FolBA) is used instead of serum calibration to test serum samples. This results in falsely low folate measurements, which could lead to missed diagnoses or inadequate treatment of folate deficiency.
Healthcare facilities and laboratory professionals using this test kit should stop using affected lots and contact Siemens Healthcare Diagnostics for further guidance. The recall affects all current and future lots until the Instructions for Use are updated with corrected procedures. No illnesses or injuries have been reported at this time.
The recalled product
- Product
- Atellica IM Folate 140 test kit- For in vitro diagnostic use in the quantitative determination of folate in human serum and red blood cells. Siemens Material Number (SMN): 10995572
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Affected units
- 13,843
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- 27949339
- 41143343
- 41144343
Distribution
Part of a larger recall action
This product is one of 6 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
Same hazard · measurement bias
See all →- HighEmano Flow Uroflowmetry App Recalled Over Biased Flow Estimates
FDA (Devices) · 2026-07-29
- HighStago D-dimer assay shows positive bias across entire analytical range
FDA (Devices) · 2026-03-25
- HighCapillary tubes recalled over a positive bias in potassium results
FDA (Devices) · 2026-02-25
- HighVITROS Chemistry CRP Diagnostic Slides May Underreport Elevated Results
FDA (Devices) · 2024-12-04
- Highepoc BGEM BUN Test Cards recalled for sodium measurement bias
FDA (Devices) · 2024-11-13